Literature DB >> 9171347

The Fc receptor gamma-chain and the tyrosine kinase Syk are essential for activation of mouse platelets by collagen.

A Poole1, J M Gibbins, M Turner, M J van Vugt, J G van de Winkel, T Saito, V L Tybulewicz, S P Watson.   

Abstract

Activation of mouse platelets by collagen is associated with tyrosine phosphorylation of multiple proteins including the Fc receptor gamma-chain, the tyrosine kinase Syk and phospholipase Cgamma2, suggesting that collagen signals in a manner similar to that of immune receptors. This hypothesis has been tested using platelets from mice lacking the Fc receptor gamma-chain or Syk. Tyrosine phosphorylation of Syk and phospholipase Cgamma2 by collagen stimulation is absent in mice lacking the Fc receptor gamma-chain. Tyrosine phosphorylation of phospholipase Cgamma2 by collagen stimulation is also absent in mice platelets which lack Syk, although phosphorylation of the Fc receptor gamma-chain is maintained. In contrast, tyrosine phosphorylation of platelet proteins by the G protein-coupled receptor agonist thrombin is maintained in mouse platelets deficient in Fc receptor gamma-chain or Syk. The absence of Fc receptor gamma-chain or Syk is accompanied by a loss of secretion and aggregation responses in collagen- but not thrombin-stimulated platelets. These observations provide the first direct evidence of an essential role for the immunoreceptor tyrosine-based activation motif (ITAM) in signalling by a non-immune receptor stimulus.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9171347      PMCID: PMC1169834          DOI: 10.1093/emboj/16.9.2333

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  33 in total

1.  Platelet adhesion to collagen in individuals lacking glycoprotein IV.

Authors:  L McKeown; M Vail; S Williams; W Kramer; K Hansmann; H Gralnick
Journal:  Blood       Date:  1994-05-15       Impact factor: 22.113

2.  Collagen induces normal signal transduction in platelets deficient in CD36 (platelet glycoprotein IV).

Authors:  J L Daniel; C Dangelmaier; R Strouse; J B Smith
Journal:  Thromb Haemost       Date:  1994-03       Impact factor: 5.249

3.  FcR gamma chain deletion results in pleiotrophic effector cell defects.

Authors:  T Takai; M Li; D Sylvestre; R Clynes; J V Ravetch
Journal:  Cell       Date:  1994-02-11       Impact factor: 41.582

4.  Syk tyrosine kinase required for mouse viability and B-cell development.

Authors:  A M Cheng; B Rowley; W Pao; A Hayday; J B Bolen; T Pawson
Journal:  Nature       Date:  1995-11-16       Impact factor: 49.962

5.  Activation of p72syk by thrombin in a cell-free system.

Authors:  K Sada; S Yanagi; H Yamamura
Journal:  Biochem Biophys Res Commun       Date:  1994-04-15       Impact factor: 3.575

6.  Platelets deficient in glycoprotein IIIb aggregate normally to collagens type I and III but not to collagen type V.

Authors:  B Kehrel; A Kronenberg; J Rauterberg; D Niesing-Bresch; U Niehues; J Kardoeus; B Schwippert; D Tschöpe; J van de Loo; K J Clemetson
Journal:  Blood       Date:  1993-12-01       Impact factor: 22.113

7.  Evidence for a role for tyrosine phosphorylation of phospholipase C gamma 2 in collagen-induced platelet cytosolic calcium mobilization.

Authors:  J L Daniel; C Dangelmaier; J B Smith
Journal:  Biochem J       Date:  1994-09-01       Impact factor: 3.857

8.  Isolation and purification of collagen alpha 1(I) receptor from human platelet membrane.

Authors:  T M Chiang; A H Kang
Journal:  J Biol Chem       Date:  1982-07-10       Impact factor: 5.157

9.  Protein-tyrosine kinase p72syk is activated by thrombin and is negatively regulated through Ca2+ mobilization in platelets.

Authors:  T Taniguchi; H Kitagawa; S Yasue; S Yanagi; K Sakai; M Asahi; S Ohta; F Takeuchi; S Nakamura; H Yamamura
Journal:  J Biol Chem       Date:  1993-02-05       Impact factor: 5.157

10.  Differential control of the tyrosine kinases Lyn and Syk by the two signaling chains of the high affinity immunoglobulin E receptor.

Authors:  M H Jouvin; M Adamczewski; R Numerof; O Letourneur; A Vallé; J P Kinet
Journal:  J Biol Chem       Date:  1994-02-25       Impact factor: 5.157

View more
  107 in total

1.  High-content live-cell imaging assay used to establish mechanism of trastuzumab emtansine (T-DM1)--mediated inhibition of platelet production.

Authors:  Jonathan N Thon; Matthew T Devine; Antonija Jurak Begonja; Jay Tibbitts; Joseph E Italiano
Journal:  Blood       Date:  2012-06-04       Impact factor: 22.113

2.  The tandem Src homology 2 domain of the Syk kinase: a molecular device that adapts to interphosphotyrosine distances.

Authors:  Sangaralingam Kumaran; Richard A Grucza; Gabriel Waksman
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

3.  Distinct roles of GPVI and integrin alpha(2)beta(1) in platelet shape change and aggregation induced by different collagens.

Authors:  Gavin E Jarvis; Ben T Atkinson; Daniel C Snell; Steve P Watson
Journal:  Br J Pharmacol       Date:  2002-09       Impact factor: 8.739

Review 4.  Arterial thrombosis--insidious, unpredictable and deadly.

Authors:  Shaun P Jackson
Journal:  Nat Med       Date:  2011-11-07       Impact factor: 53.440

Review 5.  The Role and Function of Fcγ Receptors on Myeloid Cells.

Authors:  Stylianos Bournazos; Taia T Wang; Jeffrey V Ravetch
Journal:  Microbiol Spectr       Date:  2016-12

6.  Evidence for the requirement of ITAM domains but not SLP-76/Gads interaction for integrin signaling in hematopoietic cells.

Authors:  Farhad Abtahian; Natalie Bezman; Regina Clemens; Eric Sebzda; Lan Cheng; Sanford J Shattil; Mark L Kahn; Gary A Koretzky
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

Review 7.  The expanding roles of ITAM adapters FcRgamma and DAP12 in myeloid cells.

Authors:  Jessica A Hamerman; Minjian Ni; Justin R Killebrew; Ching-Liang Chu; Clifford A Lowell
Journal:  Immunol Rev       Date:  2009-11       Impact factor: 12.988

8.  Synthetic glycopolymers and natural fucoidans cause human platelet aggregation via PEAR1 and GPIbα.

Authors:  Caroline Kardeby; Knut Fälker; Elizabeth J Haining; Maarten Criel; Madelene Lindkvist; Ruben Barroso; Peter Påhlsson; Liza U Ljungberg; Mattias Tengdelius; G Ed Rainger; Stephanie Watson; Johannes A Eble; Marc F Hoylaerts; Jonas Emsley; Peter Konradsson; Steve P Watson; Yi Sun; Magnus Grenegård
Journal:  Blood Adv       Date:  2019-02-12

9.  A novel antiplatelet antibody therapy that induces cAMP-dependent endocytosis of the GPVI/Fc receptor gamma-chain complex.

Authors:  Hiroshi Takayama; Yoshitaka Hosaka; Kazuyuki Nakayama; Kamon Shirakawa; Katsuki Naitoh; Tomokazu Matsusue; Mikihiko Shinozaki; Motoyasu Honda; Yukiko Yatagai; Tetsushi Kawahara; Jiro Hirose; Tooru Yokoyama; Michiru Kurihara; Shoji Furusako
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

10.  The heptapeptide LSARLAF mediates platelet activation through phospholipase Cgamma2 independently of glycoprotein IIb-IIIa.

Authors:  Andrew C Pearce; Peter Wonerow; Stuart J Marshall; Jon Frampton; T Kent Gartner; Steve P Watson
Journal:  Biochem J       Date:  2004-02-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.